【摘要】 目的探讨射频消融治疗肝癌的疗效、适应证及并发症。方法对956例肝癌患者共计1873个肿块进行射频消融治疗,其中转移性肿瘤381例,原发性肿瘤575例,肿瘤直径1~17cm,平均2.4cm。结果 956例肝癌患者均成功进行了射频消融,1、2、3年的生存率分别为81.14%、52.65%、39.12%。术后出现肝脓肿4例,大量胸水5例,出血1例,胆漏1例,无一例发生与射频相关的死亡。结论射频消融治疗肝癌具有安全、微创、疗效可靠等特点,尤其对小肝癌疗效更佳。更多还原

【Abstract】 Objective To evaluate radiofrequency ablation(RFA) for the treatment of liver malignant tumor. Methods In this study, 956 patients with 1873 tumors underwent RFA. 575 cases were Primary, 381 cases were metastasis, Tumor size varied from 1 cm to 17cm in diameter, mean was 2.4cm. Results All the cases were successful underwent RFA.The cumulative survival rates of RFA at 1, 2and 3 years were 81.14%, 52.65% and 39.12%. RFA for liver malignant tumors complicated with hepatic abscess in 0.41%(4/956), hydrothorax in 0.52%(5/956), biliary leakage in 0.10%(1/956), bleeding in 0.10%(1/956). Conclusion Treating liver malignant tumors with RFA is safe, minimally invasive and reliable, curative effect for the small liver tumor is better.更多还原